Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 637

Document Document Title
WO/2016/158066A1
The present invention provides a novel cyanic acid ester compound capable of giving a cured object which has excellent solubility in solvents and a low coefficient of thermal expansion and is excellent in terms of flame retardancy and he...  
WO/2016/058056A1
The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.  
WO/2016/021511A1
 This underlayer film-forming composition for lithography contains a compound represented by specific formula (1) and 20 to 99 mass% of a solvent component (S), wherein the compound represented by formula (1) comprises 27 to 100 mass% ...  
WO/2015/168465A1
This invention relates to compounds that inhibit creatine transport and/or creatine kinase, pharmaceutical compositions including such compounds, and methods of utilizing such compounds and compositions for the treatment of cancer.  
WO/2015/060418A1
Provided is a novel cyanic acid ester compound which has excellent solubility in solvents and enables the production of a cured article having a low thermal expansion coefficient and excellent flame retardancy and heat resistance. The pr...  
WO/2014/143561A1
Compounds of formula (I): where R1, R2, R3, R4a, R4b, R5, R6 and R7 are defined herein, or stereoisomers or pharmaceutically acceptable salts thereof, are described herein. Such compounds have activity as SHIP1 modulators, and thus may b...  
WO/2014/065422A9
The present invention addresses the problem of providing: an efficient production method for a cyanogen halide with which secondary reactions are inhibited in the production of cyanate ester compounds; and a production method with which ...  
WO/2014/065422A1
The present invention addresses the problem of providing: an efficient production method for a cyanogen halide with which secondary reactions are inhibited in the production of cyanate ester compounds; and a production method with which ...  
WO/2014/040052A2
The present application relates to: (a) compounds of Formula (I): and salts thereof, wherein Y and Z are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, sal...  
WO/2013/126643A1
Disclosed herein are polycyanates of the formula: where R, m, Q, p and Z are as defined herein. Also disclosed are methods of curing said polycyanates and methods of using said polycyanates to provide high Tg thermoset products.  
WO/2012/121146A1
Electrode active material has an organic compound as a principal constituent thereof that contains a pyracene structure represented by the general formula as a constitutional unit thereof. This pyracene structure contains a plurality of ...  
WO/2012/106588A2
The present invention encompasses the finding that improvements can be achieved in manufacture of isocyanates through the use of a substitute for or a precursor of phosgene. Methods and compositions utilized in accordance with the presen...  
WO/2012/106588A3
The present invention encompasses the finding that improvements can be achieved in manufacture of isocyanates through the use of a substitute for or a precursor of phosgene. Methods and compositions utilized in accordance with the presen...  
WO/2012/057144A1
Provided is a novel difunctional cyanate ester of a di-cyanatophenyl type, which can obtain a cured product that is in liquid form at room temperature and has excellent low thermal expansion. A cyanate ester compound represented by formu...  
WO/2012/029672A1
The present invention relates to amine derivatives each represented by chemical formula (I) (wherein Ar represents a phenyl group or the like; R1 represents a hydrogen atom or the like; R2 represents a C1-6 alkylcarbonyl group or the lik...  
WO/2011/136844A1
Embodiments of the present disclosure include polycyclopentadiene compounds represented by Formula (I) : in which each X is either a hydrogen or a cyano group ( N≡C-), n has an average value from zero to 20; each m independently has a ...  
WO/2011/110653A1
Solution of conductive molecular materials and electromagnetic absorbents produced from these solutions. The invention relates to a stable solution of molecular material, characterized in that it comprises: - a first type of organic or o...  
WO/2011/085280A1
Disclosed herein are compositions comprising a reactive monomer, and, in particular, coating and/or reactive coating compositions. More particularly, compositions containing monomers comprising a lactam moiety, a urethane or urea functio...  
WO/2011/022457A1
Compounds comprising a lactam moiety, and a urethane or urea functional group are presented. By a preferred synthesis route, they are prepared using at least one polymerizable compound comprising an isocyanate moiety and reacting it with...  
WO/2010/123838A2
The present invention relates to inhibitors of 11- β-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, centr...  
WO/2010/123838A3
The present invention relates to inhibitors of 11- β-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, centr...  
WO/2010/101294A1
There is provided an antistatic agent for a polyurethane resin which exhibits sufficient antistatic properties with a smaller addition amount and in which an effective component has no halogen atom. As the effective component of an antis...  
WO/2010/064655A1
An indenofluorenedione derivative having a structure represented by formula (I) (wherein Ar1 represents a fused ring having 6-24 nuclear carbon atoms, or the like; ar1 and ar2 represent formula (i) or/and formula (ii); and x1 and x2 each...  
WO/2010/010174A1
The present invention relates to compounds defined by formula (I) wherein the group R is defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11 β-hydroxysteroid dehydrogenase...  
WO/2009/114465A1
Aromatic dicyanate compounds which comprise aliphatic moieties having at least about six carbon atoms and resins and thermoset products based on these compounds.  
WO/2009/011327A1
Disclosed is an organic electroluminescent device material containing an indenofluorenedione derivative represented by the following formula (I). (In the formula, X1 and X2 may be the same or different and each represents a specific diva...  
WO/2008/074755A3
This invention relates to novel cinnamic amide derivatives that are found to be potent modulators of ion channels and, as such, they are valuable candidates for the treatment of diseases or disorders as diverse as those which are respons...  
WO/2008/074755A2
This invention relates to novel cinnamic amide derivatives that are found to be potent modulators of ion channels and, as such, they are valuable candidates for the treatment of diseases or disorders as diverse as those which are respons...  
WO/2008/034095A3
Disclosed are processes for preparing a protected trifluorothreonine, or salt thereof or carboxylate derivative thereof, the process comprising: dihydroxylation of an alkene to yield a dihydroxyl compound; conversion of the dihydroxyl co...  
WO/2008/024303A3
Disclosed are compounds of formulae (I), (III), (IV), (VII), (X), (XI), (XII), (XIII) and (XIV), wherein the variabables are as defined in the claims, and methods of using compounds of the invention for treating a subject with a prolifer...  
WO/2007/116750A1
Disclosed is a material for organic electroluminescent devices which contains a quinone derivative represented by one of the formulae (1)-(3) below. [In the formulae, R1-R16 respectively represent a hydrogen, a halogen, a cyano group, an...  
WO/2007/026373A3
An improved process for the preparation of Rivastigmine is disclosed.  
WO2006116038A3
Provided are methods for the separation of mono-substituted probucol derivatives from a mixture of both mono- and di-substituted probucol derivatives. In particular, methods are provided for the separation of mono-carboxy substituted pro...  
WO/2006/124710A1
The present invention is directed to D-homoandrosta-17-yl-carbamate derivatives as selective glucocorticoid receptor ligands useful for treating a variety of autoimmune and inflammatory diseases or conditions. Pharmaceutical compositions...  
WO2006073456A3
A method of treating coronavirus infection. The method includes administering to a subject suffering from or being at risk of suffering from such infection an effective amount of a compound of formula (I). Each variable in this formula i...  
WO/2006/088556A1
Charge transport materials are provided, and methods for making the same.  
WO2005102305A3
ABSTRACT The present invention provides novel compositions of allosteric hemoglobin modifiers which are substantially free of impurities, specifically polymeric impurities. In one embodiment, the novel compositions contain an allosteric ...  
WO/2006/038606A1
Disclosed are a compound represented by the formula (I) below, a pharmaceutically acceptable salt thereof, a solvate of those, and a pharmaceutical composition containing such a compound. (In the formula, X1 represents N or CR2; X2 repre...  
WO/2006/017406A1
cyanoamidines compounds of formula (I) and (II) and their derivatives wherein R1 - R12 are as defined in the specification act as antagonists of the P2X7 receptor. These compounds are particularly useful in the treatment of pain, inflamm...  
WO2004098512A3
The present application describes modulators of MCP 1 of formula (I) or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.  
WO/2005/079270A3
The present invention provides aryl nitrones, compositions comprising the same and methods of their use for the treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine mediated conditions.  
WO2005054174A3
The invention relates to compounds for modulating the glycolysis enzyme complex and the transaminase complex, pharmaceutical compositions containing said compounds, and to the uses of said compounds for the production of pharmaceutical c...  
WO/2005/068412A1
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders c...  
WO2004089890A3
Disclosed is a new process and intermediates for preparing benzazepines of Formula wherein R<1> and R<2> are as defined herein.  
WO2005007104A3
The invention provides the following formula (I) and uses thereof: wherein each Ak is independently selected from the group consisting of alkyl; Cy is selected from the group consisting of cycloalkyl, substituted cycloalkyl, heterocycle,...  
WO/2005/054174A2
The invention relates to compounds for modulating the glycolysis enzyme complex and the transaminase complex, pharmaceutical compositions containing said compounds, and to the uses of said compounds for the production of pharmaceutical c...  
WO/2005/007104A2
The invention provides the following formula (I) and uses thereof: wherein each Ak is independently selected from the group consisting of alkyl; Cy is selected from the group consisting of cycloalkyl, substituted cycloalkyl, heterocycle,...  
WO/2004/101501A1
The invention relates to a novel method for producing dimethyl cyanimidocarbonate (DCC, 3,3-dimethoxy-2-azaprop-2-ene nitrile) from sodium cyanide, methanol, chlorine gas and cyanamide.  
WO/2004/098512A2
The present application describes modulators of MCP 1 of formula (I) or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.  
WO/2004/089890A2
Disclosed is a new process and intermediates for preparing benzazepines of Formula wherein R1 and R2 are as defined herein.  

Matches 1 - 50 out of 637